Audentes Therapeutics, Inc. Increase (Decrease) in Restricted Cash
Audentes Therapeutics, Inc. reported Increase (Decrease) in Restricted Cash of $90.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-13.
Discontinued › Notes
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2017-03-13
- Audentes Therapeutics, Inc. increase (decrease) in restricted cash for the quarter ending 2016-12-31 was -$422.00K, a 144.42% decline year-over-year.
- Audentes Therapeutics, Inc. increase (decrease) in restricted cash for the quarter ending 2016-09-30 was -$4.20M, a 257.74% decline year-over-year.
- Audentes Therapeutics, Inc. increase (decrease) in restricted cash for the quarter ending 2015-12-31 was $950.00K.
- Audentes Therapeutics, Inc. increase (decrease) in restricted cash for the quarter ending 2015-09-30 was $2.66M.
- Audentes Therapeutics, Inc. increase (decrease) in restricted cash for fiscal 2016 was $90.00K, a 97.51% decline from fiscal 2015.
- Audentes Therapeutics, Inc. increase (decrease) in restricted cash for fiscal 2015 was $3.61M.
- Audentes Therapeutics, Inc. increase (decrease) in restricted cash for fiscal 2014 was $0.00.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$422.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$4.62M derived: sum of 2 quarters · filed 2017-03-13 | $90.00K 10-K · filed 2017-03-13 | |
| 2016-09-30 | -$4.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $512.00K 10-Q · filed 2016-11-10 | ||
| 2016-06-30 | $4.71M 10-Q · filed 2016-09-01 | |||
| 2015-12-31 | $950.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $3.61M derived: sum of 2 quarters · filed 2017-03-13 | $3.61M 10-K · filed 2017-03-13 | |
| 2015-09-30 | $2.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $2.66M 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-09-01 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-13 |